STOCKHOLM, Feb. 4, 2022 /PRNewswire/ — Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the third quarter 2021/22 at 10:00 a.m. CET on February 24. The interim report for the third quarter will be published at 7:30 a.m. CET on the same day.
The company’s development will be presented by Elekta’s President and CEO Gustaf Salford together with CFO Tobias Hägglöv. After the presentation, held in English, a Q&A session will follow.
The presentation will be broadcasted live on the web. It will be necessary to join the phone conference if you plan to ask questions. A recording of the webcast can be found on Elekta’s website after the call.
Time: Thursday, February 24, at 10:00 a.m. CET
Telephone numbers to join phone conference:
UK: +44 333 300 9030
USA: +1 646 722 4902
Sweden: +46 8 505 583 65
For further information, please contact:
Cecilia Ketels, Head of Investor Relations
Tel: +46-76-611-76-25, e-mail: firstname.lastname@example.org
Time zone: CET (Central European Time)
As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it’s personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope.
Elekta is headquartered in Stockholm, Sweden, with offices in more than 120 countries and listed on Nasdaq Stockholm.
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
Invitation to the presentation of Elekta’s Q3
The content is by PR Newswire. Headlines of Today Media is not responsible for the content provided or any links related to this content. Headlines of Today Media is not responsible for the correctness, topicality or the quality of the content.